{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T03:27:23Z","timestamp":1786505243348,"version":"build-2736575974"},"reference-count":111,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012576","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.prp.2026.156621","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T15:37:00Z","timestamp":1783957020000},"page":"156621","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Recent advances in understanding the role of chemokines in breast cancer microenvironment remodelling"],"prefix":"10.1016","volume":"286","author":[{"given":"Xiaorong","family":"Qiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiting","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junjie","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunlin","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2910-7904","authenticated-orcid":false,"given":"Chenyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib1","article-title":"Cancer statistics, 2026","volume":"76","author":"Siegel","year":"2026","journal-title":"CA A Cancer J Clin"},{"issue":"6","key":"10.1016\/j.prp.2026.156621_bib2","doi-asserted-by":"crossref","first-page":"960","DOI":"10.3390\/genes13060960","article-title":"The history of early breast cancer treatment","volume":"13","author":"Ben-Dror","year":"2022","journal-title":"Genes"},{"key":"10.1016\/j.prp.2026.156621_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol. Ther."},{"issue":"18","key":"10.1016\/j.prp.2026.156621_bib4","doi-asserted-by":"crossref","first-page":"9804","DOI":"10.3390\/ijms22189804","article-title":"Chemokine-directed tumor microenvironment modulation in cancer immunotherapy","volume":"22","author":"Bule","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib5","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1038\/s41467-022-29151-5","article-title":"S100A9-CXCL12 activation in BRCA1-mutant breast cancer promotes an immunosuppressive microenvironment associated with resistance to immunotherapy","volume":"13","author":"Li","year":"2022","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.prp.2026.156621_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1002\/path.5324","article-title":"POU1F1 transcription factor promotes breast cancer metastasis via recruitment and polarization of macrophages","volume":"249","author":"Seoane","year":"2019","journal-title":"J. Pathol."},{"issue":"12","key":"10.1016\/j.prp.2026.156621_bib7","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1158\/1541-7786.MCR-21-0243","article-title":"Opposing effects of granulocyte colony-stimulating factor on the Initiation and progression of breast cancer bone metastases","volume":"19","author":"Hiraga","year":"2021","journal-title":"Mol. Cancer Res. MCR"},{"key":"10.1016\/j.prp.2026.156621_bib8","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41523-017-0008-8","article-title":"Human brain metastatic stroma attracts breast cancer cells via chemokines CXCL16 and CXCL12","volume":"3","author":"Chung","year":"2017","journal-title":"NPJ Breast Cancer"},{"issue":"5","key":"10.1016\/j.prp.2026.156621_bib9","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1593\/neo.10200","article-title":"Loss of transforming growth factor-beta signaling in mammary fibroblasts enhances CCL2 secretion to promote mammary tumor progression through macrophage-dependent and-independent mechanisms","volume":"12","author":"Hembruff","year":"2010","journal-title":"Neoplasia N. Y N."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib10","doi-asserted-by":"crossref","first-page":"3543","DOI":"10.1038\/s41467-021-23946-8","article-title":"Tumor microenvironmental cytokines bound to cancer exosomes determine uptake by cytokine receptor-expressing cells and biodistribution","volume":"12","author":"Lima","year":"2021","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib11","doi-asserted-by":"crossref","first-page":"2705","DOI":"10.1038\/s41467-018-05030-w","article-title":"Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases","volume":"9","author":"Gril","year":"2018","journal-title":"Nat. Commun."},{"issue":"10","key":"10.1016\/j.prp.2026.156621_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/s41419-023-06230-z","article-title":"Targeting cancer-associated adipocyte-derived CXCL8 inhibits triple-negative breast cancer progression and enhances the efficacy of anti-PD-1 immunotherapy","volume":"14","author":"Huang","year":"2023","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.prp.2026.156621_bib13","doi-asserted-by":"crossref","first-page":"757","DOI":"10.3389\/fimmu.2019.00757","article-title":"Tumor-stroma-inflammation networks promote pro-metastatic chemokines and aggressiveness characteristics in triple-negative breast cancer","volume":"10","author":"Liubomirski","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.prp.2026.156621_bib14","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ymthe.2021.07.003","article-title":"A chemokine regulatory loop induces cholesterol synthesis in lung-colonizing triple-negative breast cancer cells to fuel metastatic growth","volume":"30","author":"Han","year":"2022","journal-title":"Mol. Ther. J. Am. Soc. Gene Ther."},{"key":"10.1016\/j.prp.2026.156621_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2020.120640","article-title":"Elucidating cancer-vascular paracrine signaling using a human organotypic breast cancer cell extravasation model","volume":"270","author":"Humayun","year":"2021","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12860-022-00416-7","article-title":"Uncarboxylated osteocalcin promotes proliferation and metastasis of MDA-MB-231 cells through TGF-\u03b2\/SMAD3 signaling pathway","volume":"23","author":"Xu","year":"2022","journal-title":"BMC Mol. Cell. Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib17","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41419-018-1258-6","article-title":"CUL1 promotes breast cancer metastasis through regulating EZH2-induced the autocrine expression of the cytokines CXCL8 and IL11","volume":"10","author":"Huang","year":"2018","journal-title":"Cell. Death Dis."},{"key":"10.1016\/j.prp.2026.156621_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.657158","article-title":"Breast tumor-derived exosomal microRNA-200b-3p promotes specific organ metastasis through regulating CCL2 expression in lung epithelial cells","volume":"9","author":"Gu","year":"2021","journal-title":"Front. Cell. Dev. Biol."},{"issue":"7355","key":"10.1016\/j.prp.2026.156621_bib19","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature10138","article-title":"CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasis","volume":"475","author":"Qian","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neo.2015.11.013","article-title":"Targeting of CCL2-CCR2-Glycosaminoglycan axis using a CCL2 decoy protein attenuates metastasis through inhibition of tumor cell seeding","volume":"18","author":"Roblek","year":"2016","journal-title":"Neoplasia N. Y N."},{"issue":"6","key":"10.1016\/j.prp.2026.156621_bib21","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s11914-019-00545-7","article-title":"Monocyte chemoattractant protein-1 (MCP-1\/CCL2) drives Activation of bone remodelling and skeletal metastasis","volume":"17","author":"Mulholland","year":"2019","journal-title":"Curr. Osteoporos. Rep."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib22","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"issue":"4","key":"10.1016\/j.prp.2026.156621_bib23","doi-asserted-by":"crossref","first-page":"4002","DOI":"10.3390\/ijms24044002","article-title":"Crosstalk of inflammatory cytokines within the breast tumor microenvironment","volume":"24","author":"Habanjar","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.prp.2026.156621_bib24","doi-asserted-by":"crossref","first-page":"R87","DOI":"10.1186\/bcr2944","article-title":"Breast cancer biological subtypes and protein expression predict for the preferential distant metastasis sites: a nationwide cohort study","volume":"13","author":"Sihto","year":"2011","journal-title":"Breast Cancer Res. BCR"},{"issue":"3","key":"10.1016\/j.prp.2026.156621_bib25","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10549-018-4796-9","article-title":"The relationship between tumour size, nodal status and distant metastases: on the origins of breast cancer","volume":"170","author":"Sopik","year":"2018","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.prp.2026.156621_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omto.2022.03.004","article-title":"CCL18 promotes breast cancer progression by exosomal miR-760 activation of ARF6\/Src\/PI3K\/Akt pathway","volume":"25","author":"Huang","year":"2022","journal-title":"Mol. Ther. Oncolytics"},{"issue":"21","key":"10.1016\/j.prp.2026.156621_bib27","doi-asserted-by":"crossref","first-page":"5849","DOI":"10.1158\/1078-0432.CCR-13-2158","article-title":"The cancer diaspora: Metastasis beyond the seed and soil hypothesis","volume":"19","author":"Pienta","year":"2013","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13058-019-1114-3","article-title":"CXCL17-derived CD11b+Gr-1+ myeloid-derived suppressor cells contribute to lung metastasis of breast cancer through platelet-derived growth factor-BB","volume":"21","author":"Hsu","year":"2019","journal-title":"Breast Cancer Res. BCR"},{"issue":"2","key":"10.1016\/j.prp.2026.156621_bib29","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","article-title":"Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models","volume":"21","author":"Keklikoglou","year":"2019","journal-title":"Nat. Cell. Biol."},{"issue":"7","key":"10.1016\/j.prp.2026.156621_bib30","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1038\/s41423-023-01013-0","article-title":"The chemokine monocyte chemoattractant protein-1\/CCL2 is a promoter of breast cancer metastasis","volume":"20","author":"Yoshimura","year":"2023","journal-title":"Cell. Mol. Immunol."},{"issue":"5","key":"10.1016\/j.prp.2026.156621_bib31","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.7150\/thno.79250","article-title":"Tumor-derived Cav-1 promotes pre-metastatic niche formation and lung metastasis in breast cancer","volume":"13","author":"Wang","year":"2023","journal-title":"Theranostics"},{"issue":"10","key":"10.1016\/j.prp.2026.156621_bib32","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1111\/cas.15507","article-title":"Tumor cell-released LC3-positive EVs promote lung metastasis of breast cancer through enhancing premetastatic niche formation","volume":"113","author":"Sun","year":"2022","journal-title":"Cancer Sci."},{"issue":"12","key":"10.1016\/j.prp.2026.156621_bib33","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1158\/1078-0432.CCR-18-1294","article-title":"A novel ACKR2-dependent role of fibroblast-derived CXCL14 in epithelial-to-mesenchymal transition and metastasis of breast cancer","volume":"25","author":"Sj\u00f6berg","year":"2019","journal-title":"Clin. Cancer Res. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.prp.2026.156621_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215781","article-title":"Exosomes deliver lncRNA DARS-AS1 siRNA to inhibit chronic unpredictable mild stress-induced TNBC metastasis","volume":"543","author":"Liu","year":"2022","journal-title":"Cancer Lett."},{"issue":"2","key":"10.1016\/j.prp.2026.156621_bib35","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1021\/acsbiomaterials.2c01388","article-title":"Application of a dual-Probe coloading nanodetection system in the process monitoring and efficacy assessment of photodynamic therapy: an in vitro study","volume":"9","author":"Dong","year":"2023","journal-title":"ACS Biomater. Sci. Eng."},{"key":"10.1016\/j.prp.2026.156621_bib36","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.pbiomolbio.2019.11.007","article-title":"Recent treatment progress of triple negative breast cancer","volume":"151","author":"Chang-Qing","year":"2020","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"4","key":"10.1016\/j.prp.2026.156621_bib37","doi-asserted-by":"crossref","first-page":"mjad025","DOI":"10.1093\/jmcb\/mjad025","article-title":"CSF2 upregulates CXCL3 expression in adipocytes to promote metastasis of breast cancer via the FAK signaling pathway","volume":"15","author":"He","year":"2023","journal-title":"J. Mol. Cell. Biol."},{"issue":"4","key":"10.1016\/j.prp.2026.156621_bib38","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.7150\/ijbs.65227","article-title":"Cancer-associated adipocytes promote the invasion and metastasis in breast cancer through LIF\/CXCLs positive feedback loop","volume":"18","author":"Zhou","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib39","doi-asserted-by":"crossref","first-page":"16351","DOI":"10.1038\/s41598-019-52746-w","article-title":"Reduced RhoA expression enhances breast cancer metastasis with a concomitant increase in CCR5 and CXCR4 chemokines signaling","volume":"9","author":"Kalpana","year":"2019","journal-title":"Sci. Rep."},{"issue":"16","key":"10.1016\/j.prp.2026.156621_bib40","doi-asserted-by":"crossref","first-page":"9314","DOI":"10.3390\/ijms23169314","article-title":"CXCL14 attenuates triple-negative breast cancer progression by regulating immune profiles of the tumor microenvironment in a T cell-dependent manner","volume":"23","author":"Gibbs","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.prp.2026.156621_bib41","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1158\/2326-6066.CIR-20-0327","article-title":"The chemokine CX3CL1 improves trastuzumab efficacy in HER2 low-expressing cancer in vitro and in vivo","volume":"9","author":"Dreyer","year":"2021","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.prp.2026.156621_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/978-3-642-21892-7_11","article-title":"Osteolytic and osteoblastic bone metastases: two extremes of the same spectrum?","volume":"192","author":"Ortiz","year":"2012","journal-title":"Recent. Results Cancer Res. Fortschr. Krebsforsch. Progres. Dans Rech. Sur Cancer"},{"key":"10.1016\/j.prp.2026.156621_bib43","doi-asserted-by":"crossref","DOI":"10.1155\/2022\/4123622","article-title":"Prominin 1 significantly correlated with bone metastasis of breast cancer and influenced the patient\u2019s prognosis","volume":"2022","author":"Yu","year":"2022","journal-title":"BioMed. Res. Int."},{"key":"10.1016\/j.prp.2026.156621_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.bbrc.2020.12.016","article-title":"Mechanically stimulated osteocytes promote the proliferation and migration of breast cancer cells via a potential CXCL1\/2 mechanism","volume":"534","author":"Dwivedi","year":"2021","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"19","key":"10.1016\/j.prp.2026.156621_bib45","doi-asserted-by":"crossref","first-page":"3603","DOI":"10.7150\/jca.26497","article-title":"CX3CL1 involves in breast cancer metastasizing to the spine via the Src\/FAK signaling pathway","volume":"9","author":"Liang","year":"2018","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib46","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.canlet.2016.05.005","article-title":"Essential roles of the interaction between cancer cell-derived chemokine, CCL4, and intra-bone CCR5-expressing fibroblasts in breast cancer bone metastasis","volume":"378","author":"Sasaki","year":"2016","journal-title":"Cancer Lett."},{"issue":"5","key":"10.1016\/j.prp.2026.156621_bib47","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.3390\/ijms20051237","article-title":"CXCR2: A novel mediator of mammary tumor bone metastasis","volume":"20","author":"Sharma","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib48","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3892\/ol.2014.2096","article-title":"Chemokine (C-X-C motif) receptor 4 RNA interference inhibits bone metastasis in breast cancer","volume":"8","author":"Zeng","year":"2014","journal-title":"Oncol. Lett."},{"issue":"16","key":"10.1016\/j.prp.2026.156621_bib49","article-title":"Leptin promotes bone metastasis of breast cancer by activating the SDF-1\/CXCR4 axis","volume":"12","author":"L D","year":"2020","journal-title":"Aging"},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib50","doi-asserted-by":"crossref","first-page":"4404","DOI":"10.1038\/s41467-019-12108-6","article-title":"The CXCL5\/CXCR2 axis is sufficient to promote breast cancer colonization during bone metastasis","volume":"10","author":"Romero-Moreno","year":"2019","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.prp.2026.156621_bib51","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1007\/s10585-009-9281-8","article-title":"Chemokine CCL2\/MCP-1 negatively regulates metastasis in a highly bone marrow-metastatic mouse breast cancer model","volume":"26","author":"Takahashi","year":"2009","journal-title":"Clin. Exp. Metastas-.-."},{"key":"10.1016\/j.prp.2026.156621_bib52","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/B978-0-12-811161-1.00011-6","article-title":"Systemic therapy for brain metastases","volume":"149","author":"Venur","year":"2018","journal-title":"Handb. Clin. Neurol."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib53","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12987-020-00192-6","article-title":"Serum-derived factors of breast cancer patients with brain metastases alter permeability of a human blood\u2013brain barrier model","volume":"17","author":"Curtaz","year":"2020","journal-title":"Fluids Barriers CNS"},{"issue":"11","key":"10.1016\/j.prp.2026.156621_bib54","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1080\/15548627.2017.1360466","article-title":"Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy","volume":"13","author":"Kaverina","year":"2017","journal-title":"Autophagy"},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib55","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13058-021-01412-z","article-title":"Tamoxifen suppresses brain metastasis of estrogen receptor-deficient breast cancer by skewing microglia polarization and enhancing their immune functions","volume":"23","author":"Wu","year":"2021","journal-title":"Breast Cancer Res. BCR"},{"issue":"11","key":"10.1016\/j.prp.2026.156621_bib56","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/s41556-019-0404-4","article-title":"Tumour exosomal CEMIP protein promotes cancer cell colonization in brain metastasis","volume":"21","author":"Rodrigues","year":"2019","journal-title":"Nat. Cell. Biol."},{"issue":"7576","key":"10.1016\/j.prp.2026.156621_bib57","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature15376","article-title":"Microenvironment-induced PTEN loss by exosomal microRNA primes brain metastasis outgrowth","volume":"527","author":"Zhang","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.prp.2026.156621_bib58","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.3389\/fonc.2020.01453","article-title":"The antitumor effect of gene-engineered exosomes in the treatment of brain metastasis of breast cancer","volume":"10","author":"Liu","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.prp.2026.156621_bib59","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.canlet.2016.12.028","article-title":"Induction of the MCP chemokine cluster cascade in the periphery by cancer cell-derived Ccl3","volume":"389","author":"Farmaki","year":"2017","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib60","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s13058-015-0558-3","article-title":"Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases","volume":"17","author":"Tabari\u00e8s","year":"2015","journal-title":"Breast Cancer Res. BCR"},{"issue":"7864","key":"10.1016\/j.prp.2026.156621_bib61","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41586-021-03614-z","article-title":"Hepatic stellate cells suppress NK cell-sustained breast cancer dormancy","volume":"594","author":"Correia","year":"2021","journal-title":"Nature"},{"issue":"6801","key":"10.1016\/j.prp.2026.156621_bib62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/35025220","article-title":"Angiogenesis in cancer and other diseases","volume":"407","author":"Carmeliet","year":"2000","journal-title":"Nature"},{"issue":"51","key":"10.1016\/j.prp.2026.156621_bib63","doi-asserted-by":"crossref","first-page":"85437","DOI":"10.18632\/oncotarget.13387","article-title":"Cancer cell CCL5 mediates bone marrow independent angiogenesis in breast cancer","volume":"7","author":"Sax","year":"2016","journal-title":"Oncotarget"},{"issue":"21","key":"10.1016\/j.prp.2026.156621_bib64","doi-asserted-by":"crossref","first-page":"6899","DOI":"10.1158\/0008-5472.CAN-11-1523","article-title":"Binding of the JmjC demethylase JARID1B to LSD1\/NuRD suppresses angiogenesis and metastasis in breast cancer cells by repressing chemokine CCL14","volume":"71","author":"Li","year":"2011","journal-title":"Cancer Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156621_bib65","first-page":"3633","article-title":"CXCR7 regulates breast tumor metastasis and angiogenesis in vivo and in vitro","volume":"17","author":"Qian","year":"2018","journal-title":"Mol. Med. Rep."},{"issue":"18","key":"10.1016\/j.prp.2026.156621_bib66","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.1038\/s41388-021-01758-w","article-title":"CCL8 mediates crosstalk between endothelial colony forming cells and triple-negative breast cancer cells through IL-8, aggravating invasion and tumorigenicity","volume":"40","author":"Kim","year":"2021","journal-title":"Oncogene"},{"issue":"33","key":"10.1016\/j.prp.2026.156621_bib67","doi-asserted-by":"crossref","first-page":"34758","DOI":"10.18632\/oncotarget.5325","article-title":"CCL18 from tumor-associated macrophages promotes angiogenesis in breast cancer","volume":"6","author":"Lin","year":"2015","journal-title":"Oncotarget"},{"issue":"3","key":"10.1016\/j.prp.2026.156621_bib68","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10585-019-09965-2","article-title":"Discovery of CCL18 antagonist blocking breast cancer metastasis","volume":"36","author":"Liu","year":"2019","journal-title":"Clin. Exp. Metastas-.-."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41420-023-01768-5","article-title":"BRCA1 mutation promotes sprouting angiogenesis in inflammatory cancer-associated fibroblast of triple-negative breast cancer","volume":"10","author":"Lee","year":"2024","journal-title":"Cell. Death Discov."},{"key":"10.1016\/j.prp.2026.156621_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2022.888431","article-title":"Fibroblast-derived CXCL12 increases vascular permeability in a 3-D microfluidic model independent of extracellular matrix contractility","volume":"10","author":"Holter","year":"2022","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"19","key":"10.1016\/j.prp.2026.156621_bib71","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.1158\/0008-5472.CAN-13-0926","article-title":"Obesity promotes breast cancer by CCL2-mediated macrophage recruitment and angiogenesis","volume":"73","author":"Arendt","year":"2013","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.prp.2026.156621_bib72","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1038\/s41388-017-0036-8","article-title":"Breast cancer metastasis to liver and lung is facilitated by Pit-1-CXCL12-CXCR4 axis","volume":"37","author":"Martinez-Ordo\u00f1ez","year":"2018","journal-title":"Oncogene"},{"issue":"10","key":"10.1016\/j.prp.2026.156621_bib73","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/1759-7714.14820","article-title":"Circ_0001667 accelerates breast cancer proliferation and angiogenesis through regulating CXCL10 expression by sponging miR-6838-5p","volume":"14","author":"Zhang","year":"2023","journal-title":"Thorac. Cancer"},{"issue":"8","key":"10.1016\/j.prp.2026.156621_bib74","article-title":"Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function","volume":"51","author":"Zhai","year":"2023","journal-title":"J. Int. Med. Res."},{"issue":"3","key":"10.1016\/j.prp.2026.156621_bib75","doi-asserted-by":"crossref","first-page":"819","DOI":"10.3390\/cancers15030819","article-title":"The omega-3 docosahexaenoyl ethanolamide reduces CCL5 secretion in triple negative breast cancer cells affecting tumor progression and macrophage recruitment","volume":"15","author":"Augimeri","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2026.156621_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2021.146100","article-title":"CCL5 secreted by luminal B breast cancer cells induces polarization of M2 macrophages through activation of MEK\/STAT3 signaling pathway via CCR5","volume":"812","author":"Zhu","year":"2022","journal-title":"Gene"},{"issue":"6","key":"10.1016\/j.prp.2026.156621_bib77","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s10495-026-02361-8","article-title":"Succinate drives breast cancer bone metastasis by activating the HIF1\u03b1\/YTHDF1\/YAP signaling axis to upregulate chemokine CXCL5 and disrupt the bone microenvironment","volume":"31","author":"Xue","year":"2026","journal-title":"Apoptosis"},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/s13058-022-01568-2","article-title":"Steroid receptor coactivator-3 inhibition generates breast cancer antitumor immune microenvironment","volume":"4","author":"Han","year":"2022","journal-title":"Breast Cancer Res. BCR"},{"issue":"2","key":"10.1016\/j.prp.2026.156621_bib79","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1158\/0008-5472.CAN-23-0902","article-title":"HSF1 inhibits antitumor immune activity in breast cancer by suppressing CCL5 to block CD8+ T-cell recruitment","volume":"84","author":"Jacobs","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.prp.2026.156621_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216221","article-title":"Tissue factor overexpression in triple-negative breast cancer promotes immune evasion by impeding T-cell infiltration and effector function","volume":"565","author":"Ren","year":"2023","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib81","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2023.2190671","article-title":"ELK3-CXCL16 axis determines natural killer cell cytotoxicity via the chemotactic activity of CXCL16 in triple negative breast cancer","volume":"12","author":"Jung","year":"2023","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.prp.2026.156621_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-026-73788-5","article-title":"A plant vesicle-dendritic cell chimera for enhancing cancer immunotherapy","author":"Yi","year":"2026","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.prp.2026.156621_bib83","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10585-019-09965-2","article-title":"Discovery of CCL18 antagonist blocking breast cancer metastasis","volume":"36","author":"Liu","year":"2019","journal-title":"Clin. Exp. Metastas-.-."},{"issue":"4","key":"10.1016\/j.prp.2026.156621_bib84","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ccr.2011.02.006","article-title":"CCL18 from tumor-associated macrophages promotes breast cancer metastasis via PITPNM3","volume":"19","author":"Chen","year":"2011","journal-title":"Cancer Cell."},{"issue":"5","key":"10.1016\/j.prp.2026.156621_bib85","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.immuni.2016.10.032","article-title":"Regulatory T cells exhibit distinct features in human breast cancer","volume":"45","author":"Plitas","year":"2016","journal-title":"Immunity"},{"issue":"6","key":"10.1016\/j.prp.2026.156621_bib86","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1007\/s00262-022-03343-w","article-title":"CXCL9 influences the tumor immune microenvironment by stimulating JAK\/STAT pathway in triple-negative breast cancer","volume":"72","author":"Wu","year":"2023","journal-title":"Cancer Immunol. Immunother. CII"},{"issue":"7","key":"10.1016\/j.prp.2026.156621_bib87","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1172\/JCI67428","article-title":"CD4+ follicular helper T cell infiltration predicts breast cancer survival","volume":"123","author":"Gu-Trantien","year":"2013","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.prp.2026.156621_bib88","first-page":"373","article-title":"CCL19+ dendritic cells potentiate clinical benefit of anti-PD-(L)1 immunotherapy in triple-negative breast cancer","volume":"4","author":"Wu","year":"2023","journal-title":"Med. N. Y N."},{"issue":"8","key":"10.1016\/j.prp.2026.156621_bib89","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1093\/brain\/awad139","article-title":"Long-term safety and efficacy of mogamulizumab (anti-CCR4) for treating virus-associated myelopathy","volume":"146","author":"Sato","year":"2023","journal-title":"Brain J. Neurol."},{"key":"10.1016\/j.prp.2026.156621_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105010","article-title":"CXCR4 antagonist AMD3100 (plerixafor): From an impurity to a therapeutic agent","volume":"159","author":"Wang","year":"2020","journal-title":"Pharmacol. Res."},{"issue":"6","key":"10.1016\/j.prp.2026.156621_bib91","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S1470-2045(18)30147-5","article-title":"Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial","volume":"19","author":"Pernas","year":"2018","journal-title":"Lancet Oncol."},{"issue":"7","key":"10.1016\/j.prp.2026.156621_bib92","doi-asserted-by":"crossref","first-page":"4548","DOI":"10.1021\/acs.jmedchem.3c00030","article-title":"Discovery of a potent and selective CCR8 small molecular antagonist IPG7236 for the treatment of cancer","volume":"66","author":"Wu","year":"2023","journal-title":"J. Med. Chem."},{"issue":"3","key":"10.1016\/j.prp.2026.156621_bib93","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/cas.14306","article-title":"Phase I dose-escalation trial to repurpose propagermanium, an oral CCL2 inhibitor, in patients with breast cancer","volume":"111","author":"Masuda","year":"2020","journal-title":"Cancer Sci."},{"issue":"9","key":"10.1016\/j.prp.2026.156621_bib94","doi-asserted-by":"crossref","first-page":"3849","DOI":"10.1016\/j.apsb.2023.03.024","article-title":"Self-assembly of CXCR4 antagonist peptide-docetaxel conjugates for breast tumor multi-organ metastasis inhibition","volume":"13","author":"Li","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib95","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s13402-018-0415-3","article-title":"CCR5 blockage by maraviroc: a potential therapeutic option for metastatic breast cancer","volume":"42","author":"Pervaiz","year":"2019","journal-title":"Cell. Oncol. Dordr."},{"key":"10.1016\/j.prp.2026.156621_bib96","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.jconrel.2023.11.044","article-title":"CCL2 chemokine inhibition primes the tumor vasculature for improved nanomedicine delivery and efficacy","volume":"365","author":"M\u00f6ckel","year":"2023","journal-title":"J. Control. Release J. Control. Release Soc."},{"key":"10.1016\/j.prp.2026.156621_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.126147","article-title":"CL4-modified exosomes deliver lncRNA DARS-AS1 siRNA to suppress triple-negative breast cancer progression and attenuate doxorubicin resistance by inhibiting autophagy","volume":"250","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"18","key":"10.1016\/j.prp.2026.156621_bib98","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3390\/cells12182237","article-title":"The Role and Therapeutic Targeting of CCR5 in Breast Cancer","volume":"12","author":"Hamid","year":"2023","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.prp.2026.156621_bib99","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1158\/1541-7786.MCR-18-0750","article-title":"CCR2 chemokine receptors enhance growth and cell-cycle progression of breast cancer cells through SRC and PKC activation","volume":"17","author":"Yao","year":"2019","journal-title":"Mol. Cancer Res."},{"issue":"10","key":"10.1016\/j.prp.2026.156621_bib100","doi-asserted-by":"crossref","first-page":"3071","DOI":"10.3390\/cancers12103071","article-title":"The signaling duo CXCL12 and CXCR4: chemokine fuel for breast cancer tumorigenesis","volume":"12","author":"Zieli\u0144ska","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"10","key":"10.1016\/j.prp.2026.156621_bib101","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: Mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell. Prolif."},{"issue":"7525","key":"10.1016\/j.prp.2026.156621_bib102","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/nature13862","article-title":"Cessation of CCL2 inhibition accelerates breast cancer metastasis by promoting angiogenesis","volume":"515","author":"Bonapace","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.prp.2026.156621_bib103","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1685474","article-title":"Chemokine ligand 2: beyond chemotaxis-a multifaceted role in tumor progression","volume":"16","author":"Jin","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.prp.2026.156621_bib104","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.2005869","article-title":"CCL20 triggered by chemotherapy hinders the therapeutic efficacy of breast cancer","volume":"16","author":"Chen","year":"2018","journal-title":"PLoS. Biol."},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib105","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.prp.2026.156621_bib106","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.prp.2026.156621_bib107","doi-asserted-by":"crossref","first-page":"10374","DOI":"10.1038\/s41598-022-14610-2","article-title":"A comprehensive bioinformatics analysis to identify potential prognostic biomarkers among CC and CXC chemokines in breast cancer","volume":"12","author":"Hozhabri","year":"2022","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.prp.2026.156621_bib108","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3892\/or.2026.9091","article-title":"CXCL1 in triple-negative breast cancer: Mechanisms, challenges, and therapeutic opportunities (Review)","volume":"55","author":"Al Sayegh","year":"2026","journal-title":"Oncol. Rep."},{"issue":"3","key":"10.1016\/j.prp.2026.156621_bib109","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3390\/cancers15030676","article-title":"Plasma cytokines\/chemokines as predictive biomarkers for lymphedema in breast cancer patients","volume":"15","author":"Vang","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prp.2026.156621_bib110","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.omto.2020.12.011","article-title":"CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy","volume":"20","author":"Pan","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"25","key":"10.1016\/j.prp.2026.156621_bib111","doi-asserted-by":"crossref","first-page":"eabd8936","DOI":"10.1126\/sciadv.abd8936","article-title":"CD8+ T cell immunity blocks the metastasis of carcinogen-exposed breast cancer","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002748?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033826002748?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T02:40:40Z","timestamp":1786502440000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033826002748"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":111,"alternative-id":["S0344033826002748"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2026.156621","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent advances in understanding the role of chemokines in breast cancer microenvironment remodelling","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2026.156621","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"156621"}}